Page 4 - United Biosource News Today

10/20/21 Clinical Leader Newsletter

10/18/21 Clinical Leader Newsletter

08/11/21 Clinical Leader Newsletter

05/19/21 Clinical Leader Newsletter

Drug Safety Solutions and Pharmacovigilance Market Research Report, Growth Trends and Competitive Analysis 2021-2027    Drug Safety Solutions and Pharmacovigilance Market Size 2021 by Product Sales, Revenue, Price, Market Share, Growth Opportunity and Forecast to 2024 Research Report I Top key players- Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Co...

05.12.21 -- Partners Ready To Support Your Post-Approval Studies     As an established leader with decades of experience in Real-World Evidence (RWE) generation – UBC offers clients a distinct advantage as they move their specialty product from clinical development to the market.     When patients are waiting for life-altering treatments, every milestone is critical, Precision applies demonstrated expertise from quantifying the burden of disease for narrow patients populations to demonstr...

05.12.21 -- How Is The Shift To Decentralized Trials Impacting Clinical Sites?   Sponsor Is clinical development prepared for the paradigm shift caused by COVID-19? The pandemic has forced the industry to reevaluate how to engage with patients and acquire patient data without direct, in-person access. Biopharmaceutical companies, medical device companies, and CROs from around the world were surveyed to explore the impact on clinical trials in this new paradigm...

05.05.21 -- Partners Ready To Support Your Phase I-III Trials     Cytel brings its expertise in adaptive designs to the design and implementation of the industry’s most innovative clinical trials. These highly flexible trials raise peculiar challenges for enrollment, data collection and regulatory submission. Why not have the industry leaders in adaptive design working on your adaptive trials?     Are you preparing to initiate your clinical trial? Trying to get your next milestone quickly...

Posted Mar 09, 2021 UBC, a comprehensive late stage research and patient-support services organization, is announcing an offering to harness the power of real-world data (RWD) for rapid generation of insights into the safety and effectiveness of COVID-19 vaccines.     As vaccine manufacturers prepare for post authorization surveillance initiatives to generate outcome evidence in real-world settings, the ability to rapidly automate analysis of large-scale representative databases ...

Adverse Event Reporting Software Segment to Grow at Highest CAGR During 2020-2027 Pharmacovigilance and Drug Safety Software Market is expected to reach US$ 292.97 Mn in 2027 from US$ 160.67 Mn in 2019. The market is estimated to grow at a CAGR of 7.6% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance have bee...